Mechanisms of Hepatocyte Injury, Multiorgan Failure, and Prognostic Criteria in Acute Liver Failure

ABSTRACT

Acute liver failure (ALF) occurs when the rate and extent of liver cell death are not adequately balanced by regenerative activity. Two forms of liver cell death are recognized: apoptosis and necrosis. A number of causes of ALF have been shown, predominantly in experimental animal models, to induce one or the other form of liver cell death. Nonetheless, an insult capable of inducing apoptosis may cause cell death by necrosis, particularly if the degree of mitochondrial damage is sufficient to exhaust stores of adenosine triphosphate. Here we consider mechanisms of liver cell injury in ALF, including evolving knowledge of signaling pathways leading to hepatocellular apoptosis and necrosis. Factors that have an impact on the adequacy of hepatic regeneration along with the pathophysiology of complicating multiorgan failure are also reviewed. Prognostic criteria are discussed, especially in relation to current concepts of mechanisms of liver cell death and multiorgan dysfunction.

KEYWORDS

Apoptosis - necrosis - regeneration - prognosis

REFERENCES

• 1 Kaplowitz N. Mechanisms of liver cell injury.  J Hepatol . 2000;  32(Suppl 1) 39-47
• 2 Mehmet H. Apoptosis: caspases find a new place to hide.  Nature . 2000;  403 29-30
• 3 Thornberry N A, Lazebnik Y. Caspases: enemies within.  Science . 1998;  281 1309-1312
• 4 Ockner R K. Apoptosis and liver diseases: recent concepts of mechanism and significance.  J Gastroenterol Hepatol . 2001;  16 248-260
• 5 Green D R, Reed J C. Mitochondria and apoptosis.  Science . 1998;  281 1309-1312
• 6 Nagai H, Matsumaru K, Feng G, Kaplowitz N. Reduced glutathione depletion causes necrosis and sensitisation to tumor necrosis factor-a-induced apoptosis in cultured mouse hepatocytes.  Hepatology . 2002;  36 55-64
• 7 Gujral J S, Knight T R, Farhood A. et al . Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?.  Toxicological Sciences . 2002;  67 322-328
• 8 Strand S, Hofmann W J, Grambihler A. et al . Hepatic failure and liver damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis.  Nat Med . 1998;  4 588-593
• 9 Rudiger H A, Clavien P-A. Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischaemic liver.  Gastroenterology . 2002;  122 202-210
• 10 Lemaire C, Andreau K, Souvannavong V, Adam A. Inhibition of caspase induces a switch from apoptosis to necrosis.  FEBS Lett . 1998;  425 266-270
• 11 Leist M, Single B, Castoldi A F, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis.  J Exp Med . 1997;  185 1481-1486
• 12 Lemasters J. Mechanisms of hepatic toxicity versus necraptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis.  Am J Physiol . 1999;  276 G1-G6
• 13 Galle P, Krammer P. CD95-induced apoptosis in human liver disease.  Semin Liver Dis . 1998;  18 141-151
• 14 Wallach D, Boldin M, Varfolomeev E. et al . Cell death induction by receptors of the TNF family: towards a molecular understanding.  FEBS Lett . 1997;  410 96-106
• 15 Yuan J. Transducing signals of life and death.  Curr Opin Cell Biol . 1997;  9 247-251
• 16 Bradham C A, Plumpe J, Manns M P. et al . Mechanisms of hepatic toxicity. I. TNF induced liver injury.  Am J Physiol . 1998;  275 G387-G392
• 17 Wallach D, Varfolomeev E E, Malinin N L. et al . Tumour necrosis factor receptor and Fas signaling mechanisms.  Ann Rev Immunol . 1999;  17 331-367
• 18 Scaffidi C, Fulda S, Srinivasan A. et al . Two CD95 (APO-1/Fas) signaling pathways.  EMBO J . 1998;  17 1675-1687
• 19 Yin X M, Wang K, Gross A. et al . Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis.  Nature . 1999;  400 886-891
• 20 Streetz K L, Leifeld L, Grundmann D. et al . Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure.  Gastroenterology . 2000;  119 446-460
• 21 Bradham C A, Qian T, Streetz K. et al . The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release.  Mol Cell Biol . 1998;  18 6353-6364
• 22 Xu Y, Jones B, Neufeld D, Czaja M. Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor alpha toxicity.  Gastroenterology . 1998;  115 1229-1237
• 23 Leist M, Gantner F, Naumann H. et al . Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins.  Gastroenterology . 1997;  112 923-934
• 24 Xu Y, Bialik S, Jones B E. et al . NF-κB inactivation converts a hepatocyte cell line TNF-α response from proliferation to apoptosis.  Am J Physiol . 1998;  275 C1058-C1066
• 25 Liu H, Lo C R, Jones B E. et al . Inhibition of c-Myc expression sensitizes hepatocytes to tumor necrosis factor-induced apoptosis and necrosis.  J Biol Chem . 2000;  275 40155-40162
• 26 Reinhard C, Shamoon B, Shyamala V, Williams L T. Tumor necrosis factor alpha-induced activation of c-jun-N-terminal kinase is mediated by TRAF2.  EMBO J . 1997;  16 1080-1092
• 27 Chang L, Karin M. Mammalian MAP kinase signaling cascades.  Nature . 2001;  410 37-40
• 28 Liu Z G, Hsu H, Goeddel D V, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death.  Cell . 1996;  87 565-576
• 29 Liu H, Lo C R, Czaja M J. NF-κB inhibition sensitises hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun.  Hepatology . 2002;  35 772-778
• 30 Roberts R A, James N H, Cosulich S C. The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis.  Hepatology . 2000;  31 420-427
• 31 Arvelo M B, Cooper J T, Longo C. et al . A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis.  Hepatology . 2002;  35 535-543
• 32 Waltz S E, Eaton L, Toney-Earley K. et al . The cytoplasmic domain of Ron is dispensable for viability but is required to limit tissue damage following an inflammatory response.  J Clin Invest . 2001;  108 567-576
• 33 Leonis M A, Toney-Earley K, Degen S J, Waltz S E. Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure.  Hepatology . 2002;  36 1053-1060
• 34 Colletti L, Burtch G, Remick D. et al . The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion.  Transplantation . 1990;  49 268-272
• 35 Cursio R, Guggenheim J, Ricci J. et al . A caspase inhibitor fully protects rats against lethal normothermic liver ischaemia by inhibition of liver apoptosis.  FASEB J . 1999;  13 253-261
• 36 Selzner M, Rudiger H, Selzner N. et al . Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischaemia and reperfusion.  J Hepatol . 2002;  36 218-225
• 37 Peralta C, Hotter G, Closa D. et al . Protective effect preconditioning on the injury associated to hepatic ischemia-reperfusion: role of nitric oxide and adenosine.  Hepatology . 1997;  25 934-937
• 38 Teoh N, Dela Pena A, Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase, and cell cycle entry.  Hepatology . 2002;  36 94-102
• 39 Yin D P, Sankary H N, Chong A S. et al . Protective effect of ischemic preconditioning on liver-preservation-reperfusion injury in rats.  Transplantation . 1998;  66 152-157
• 40 Cutrin J C, Boveris A, Zingaro B. et al . In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment.  Hepatology . 2000;  31 622-632
• 41 Zimmerman R, Marafino B, Chan A. et al . The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo.  J Immunol . 1989;  142 1405-1409
• 42 Boess F, Bopst M, Althaus R. et al . Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-a gene knockout mice.  Hepatology . 1998;  27 1021-1029
• 43 Simpson K J, Lukacs N W, McGregor A H. et al . Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamol-induced hepatic necrosis.  J Pathol . 2000;  190 489-494
• 44 Tagawa Y, Sekikawa K, Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma (-/-) mice, but not in TNF-alpha (-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.  J Immunol . 1997;  159 1418-1428
• 45 Tsutsui H, Matsui K, Kawada N. et al . IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatoxic pathways in endotoxin-induced liver injury in mice.  J Immunol . 1997;  159 3961-3967
• 46 Tanaka Y, Takahashi A, Watanabe K. et al . A pivotal role of IL-12 in TH1-dependent mouse liver injury.  Int Immunol . 1996;  8 569-576
• 47 Schiller J H, Bittner G, Storer B, Willson J K. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.  Cancer Res . 1987;  47 2809-2813
• 48 Campbell I L, Iscaro A, Harrison L C. IFN-gamma and tumor necrosis factor-alpha.  J Immunol . 1988;  141 2325-2329
• 49 Saavedra J E, Billiar T R, Williams D L. et al . Targeting nitric oxide (NO) delivery in vivo.  J Med Chem . 1997;  40 1947-1954
• 50 Nagaki M, Tanaka M, Sugiyama A. et al . Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitised mice.  J Hepatol . 1999;  31 815-824
• 51 Bohlinger I, Leist M, Barsig J. et al . Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways.  Hepatology . 1995;  22 1829-1837
• 52 Galle P R, Hofmann W J, Walczak H. et al . Involvement of the CD95 (APO61/fas) receptor and ligand in liver damage.  J Exp Med . 1995;  182 1223-1230
• 53 Ogasawara J, Watanabe-Fukunaga R, Adachi M. et al . Lethal effects of the anti-Fas antibody in mice.  Nature . 1993;  364 806-809
• 54 Hockenbery D M, Zutter M, Hickey W. et al . BCL2 protein is topographically restricted in tissues characterised by apoptotic cell death.  Proc Natl Acad Sci USA . 1999;  88 6961-6965
• 55 de la Coste A, Fabre M, McDonnell N. et al . Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.  Am J Physiol . 1999;  277 G702-G708
• 56 Reinehr R, Graf D, Fischer R. et al . Hyperosmolarity triggers CD95 membrane trafficking and sensitizes rat hepatocytes toward CD95L-induced apoptosis.  Hepatology . 2002;  36 602-614
• 57 Schliess F, Haussinger D. The cellular hydration state: a critical determinant of cell death and survival.  Biol Chem . 2002;  383 577-583
• 58 Maeno E, Ishizaki Y, Kanaseki T. et al . Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis.  Proc Natl Acad Sci USA . 2000;  97 9487-9492
• 59 Kurz A K, Schliess F, Haussinger D. Osmotic regulation of the heat shock response in primary rat hepatocytes.  Hepatology . 1998;  28 774-781
• 60 Ando K, Moriyama T, Guidotti L G. et al . Mechanisms of class I restricted immunopathology.  J Exp Med . 1993;  178 1541-1554
• 61 Seino K, Kayagaki N, Takeda K. et al . Contribution of Fas ligand to T cell-mediated hepatic injury in mice.  Gastroenterology . 1997;  113 1315-1322
• 62 Vercammen D, Brouckaert G, Denecker G. et al . Dual signal of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways.  J Exp Med . 1998;  188 919-930
• 63 Malassagne B, Ferret P-J, Hammoud R. et al . The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse.  Gastroenterology . 2001;  121 1451-1459
• 64 Knight T R, Faeschke H. Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion.  Toxicol Appl Pharmacol . 2002;  181 133-141
• 65 Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apotosis and necrosis.  Annu Rev Physiol . 1998;  60 619-642
• 66 Vercesi A E, Kowaltowski A J, Grijalba M T. et al . The role of reactive oxygen species in mitochondrial permeability transition.  Biosci Rep . 1997;  17 43-52
• 67 Finucane D M, Bossy-Wetzel E, Waterhouse N J. et al . Bax-induced caspase activation and apoptosis via cytochrome C release from mitochondria is inhibitable by Bcl-xL.  J Biol Chem . 1999;  274 2225-2233
• 68 Li P, Nijhawan D, Budihardjo I. et al . Cytochrome C and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.  Cell . 1997;  91 479-489
• 69 Nakagawa T, Zhu H, Morishima N. et al . Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-b.  Nature . 2000;  98-103
• 70 Xie Q, Khaoustov V I, Chung C C. et al . Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation.  Hepatology . 2002;  36 592-601
• 71 Billiar T R, Curran R D, Harbrecht B G. et al . Modulation of nitric oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrite biosynthesis while promoting hepatic damage.  J Leukoc Biol . 1990;  48 565-569
• 72 Harbrecht B G, Wu B, Watkins S. et al . Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury.  Shock . 1995;  4 332-337
• 73 Cottart C H, Do L, Blanc M C. et al . Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat.  Hepatology . 1999;  29 809-813
• 74 Chu C J, Wang S S, Lee F Y. et al . Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure.  Eur J Clin Invest . 2001;  31 156-163
• 75 Yagnik G P, Takahashi Y, Tsoulfas G. et al . Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury.  Hepatology . 2002;  36 573-581
• 76 Geller D A, de Vera E M, Russell D. et al . A central role for IL-1b in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase.  J Immunol . 1995;  155 4890-4898
• 77 Geller D A, Nussler A K, Di Silvio M. et al . Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes.  Proc Natl Acad Sci USA . 1993;  90 522-526
• 78 Michael S L, Pumford N R, Mayeux P R. et al . Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species.  Hepatology . 1999;  30 186-195
• 79 Knight T R, Kurtz A, Bajt M L. et al . Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress.  Toxicol Sci . 2001;  62 212-220
• 80 Bourdi M, Masubuchi Y, Reilly T P. et al . Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase.  Hepatology . 2002;  35 289-298
• 81 Knight T R, Ho Y S, Farhood A, Jaeschke H. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione.  J Pharmacol Exp Ther . 2002;  303 468-475
• 82 Rai R M, Lee F YJ, Rosen A. et al . Impaired liver regeneration in inducible nitric oxide synthase-deficient mice.  Proc Natl Acad Sci USA . 1998;  95 13829-13834
• 83 Fausto N. Liver regeneration.  J Hepatol . 2000;  32(Suppl 1) 19-31
• 84 Nicoletti F, Zaccone P, Xiang M. et al . Essential pathogenetic role for interferon (IFN)-gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein.  Cytokine . 2000;  12 315-323
• 85 Shimizu Y, Margenthaler J A, Landeros K. et al . The resistance of P acnes-primed interferon g-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.  Hepatology . 2002;  35 805-814
• 86 Okuno K, Jinnai H, Lee Y S. et al . Interleukin 12 augments the liver-associated immunity and reduces liver metastases.  Hepatogastroenterology . 1996;  43 1196-1202
• 87 Gately M K, Warrier R R, Honasoge S. et al . Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.  Int Immunol . 1994;  6 157-167
• 88 Myers K J, Eppihimer M J, Hall L, Wolitzky B. Interleukin-12-induced adhesion molecule expression in murine liver.  Am J Pathol . 1998;  152 457-468
• 89 Nicoletti F, Di Marco R, Zaccone P. et al . Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism.  Hepatology . 2000;  32 728-733
• 90 Tanaka Y, Takahashi A, Watanabe K. et al . A pivotal role of IL-12 in TH1-dependent mouse liver injury.  Int Immunol . 1996;  8 569-576
• 91 Louis H, Le Moine A, Flamand V. et al . Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice.  Gastroenterology . 2002;  122 2001-2010
• 92 Louis H, Le Moine O, Peny M O. et al . Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.  Hepatology . 1997;  25 1382-1389
• 93 Nagaki M, Tanaka M, Sugiyama A. et al . Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitised mice.  J Hepatol . 1999;  31 815-824
• 94 Stordeur P, Goldman M. Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects.  Int Rev Immunol . 1998;  16 501-522
• 95 Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10.  J Exp Med . 1991;  174 1549-1555
• 96 Moore K W, de Waal R M, Coffman R L, O'Garra A. Interleukin-10 and the interleukin-10 receptor.  Ann Rev Imunol . 2001;  19 683-765
• 97 Trepicchio W L, Bozza M, Bouchard P, Dorner A J. Protective effect of rhIL-11 in a murine model of acetaminophen-induced hepatotoxicity.  Toxicol Pathol . 2001;  29 242-249
• 98 Bozza M, Bliss J L, Maylor R. et al . Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.  Hepatology . 1999;  30 1441-1447
• 99 Kato A, Yoshidome H, Edwards M J, Lentsch A B. Regulation of liver inflammatory injury by signal transducer and activator of transcription-6.  Am J Pathol . 2000;  157 297-302
• 100 Kovalavich K, DeAngelis R A, Li W. et al . Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice.  Hepatology . 2000;  31 149-159
• 101 Dambach D M, Watson L M, Gray K R. et al . Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse.  Hepatology . 2002;  35 1093-1103
• 102 Hogaboam C M, Bone-Larson C L, Steinhauser M L. et al . Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2.  Am J Pathol . 2000;  156 1245-1252
• 103 Leifeld L, Cheng S, Ramakers J. et al . Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B.  Hepatology . 2002;  36 1001-1008
• 104 Sheron N, Keane H, Goka J. et al . Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics.  Clin Intensive Care . 2001;  12 127-134
• 105 Nagaki M, Iwai H, Naiki T. et al . High levels of serum interleukin-10 and tumour necrosis factor-a are associated with fatality in fulminant hepatitis.  J Infect Dis . 2000;  182 1103-1108
• 106 Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction.  Hepatology . 2002;  36 395-402
• 107 Rothwell P M, Udwadia Z F, Lawler P G. Cortisol response to corticotropin and survival in septic shock.  Lancet . 1991;  337 582-583
• 108 Bihari D J, Gimson A ES, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure.  Semin Liver Dis . 1986;  6 119-128
• 109 Clemmesen O. Splanchnic circulation and metabolism in patients with acute liver failure.  Dan Med Bull . 2002;  49 177-193
• 110 Butterworth R F, Giguere J F, Michand J. et al . Ammonia: key factor in the pathogenesis of hepatic encephalopathy.  Neurochem Pathol . 1987;  6 1-12
• 111 Tofteng F, Jorgensen L, Hamsen B A. et al . Cerebral microdialyis in patients with fulminant hepatic failure.  Hepatology . 2002;  36 1333-1340
• 112 Rolando N, Wade J, Davalos M. et al . The systemic inflammatory response syndrome in acute liver failure.  Hepatology . 2000;  32 734-739
• 113 Kantrow S P, Taylor D E, Carraway M S. et al . Oxidative metabolism in rat hepatocytes and mitochondria during sepsis.  Arch Biochem Biophysics . 1997;  345 277-288
• 114 Weiss Y G, Bellin L, Kim P K. et al . Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats.  Am J Physiol Gastrointest Liver Physiol . 2001;  280 G968-G973
• 115 McCullough A J, Tavill A S. Disordered protein and energy metabolism in liver disease.  Semin Liver Dis . 1991;  11 265-277
• 116 Fryburg D A, Barrett E J. Insulin, growth hormone and IGF-1 regulation of protein metabolism.  Diabetes Reviews . 1995;  3 93-112
• 117 Clark S J, Shojaee-Moradie F, Croos P. et al . Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen.  Hepatology . 2001;  34 109-115
• 118 Hughes R D, Zhang L, Tsubouchi H. et al . Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure.  J Hepatol . 1994;  20 106-111
• 119 Miwa Y, Harrison P M, Farzaneh F. et al . Plasma levels and hepatic mRNA expression of transforming growth factor-β1 in patients with fulminant hepatic failure.  J Hepatol . 1997;  27 780-788
• 120 Mars W M, Liu M L, Kitson R P. et al . Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration.  Hepatology . 1995;  21 1695-1701
• 121 Lyons R M, Keski-Oja J, Moses H L. Proteolytic activation of latent transforming growth factor-b from fibroblast-conditioned medium.  J Cell Biol . 1988;  106 1059-1065
• 122 Pernambuco J R, Langley P G, Hughes R D. et al . Activation of the fibrinolytic system in patients with fulminant hepatic failure.  Hepatology . 1993;  18 1350-1356
• 123 Yamada H, Toda G, Yoshiba M. et al . Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant hepatic failure.  Hepatology . 1994;  19 1133-1140
• 124 Kaido T, Yamaoka S, Tanaka J. et al . Continuous HGF supply from HGF-expressing fibroblasts transplanted into spleen prevents CCl₄-induced acute liver injury in rats.  Biophys Res Commun . 1996;  218 1-5
• 125 Armenddariz-Borunda J, Katai H, Jones C M. et al . Transforming growth factor beta gene expression is transiently enhanced at a critical stage during liver regeneration after CCl4 treatment.  Lab Invest . 1993;  69 283-294
• 126 Minuk G Y, Gauthier T, Zhang X K. et al . Ciprofloxacin reverses the inhibitory effects of acute ethanol exposure on hepatic regeneration in the rat.  Hepatology . 1995;  22 1797-1800
• 127 Kaita K E, Assy N, Gauthier T. et al . The beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure.  Hepatology . 1998;  27 533-536
• 128 Anderson S P, Yoon L, Richard E B. et al . Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null mice.  Hepatology . 2002;  36 544-554
• 129 Soni M G, Mehendale H M. Role of tissue repair in toxicologic interactions among hepatotoxic organics.  Environ Health Perspect . 1998;  106 1307-1317
• 130 Lai H S, Chen W J. Alterations of remnant liver carnitine palmitoyltransferase I activity and serum carnitine concentration after partial hepatectomy in rats.  J Surg Res . 1995;  59 754-758
• 131 Blaha V, Simek J, Zadak Z. Liver regeneration in partially hepatectomized rats infused with carnitine and lipids.  Exp Toxicol Pathol . 1992;  44 165-168
• 132 Mazzoni M, Carini C, Matteucci A. et al . Increased phosphorylation of nuclear substrates for rat brain protein kinase C in regenerating rat liver nuclei.  Cell Signal . 1992;  4 313-319
• 133 Lai H S, Chen W J, Chen K M. Alteractions of high-energy phosphate, serum energy substrate and their metabolites after partial hepatectomy in rats.  J Formos Med Assoc . 1991;  90 621-625
• 134 Yanagita T, Yamamoto K, Yoshikawa K. et al . Rapid induction of CTP:phosphocholine cytidylyltransferase during liver regeneration after partial hepatectomy.  Gastroenterol Jpn . 1992;  27 265
• 135 George R, Shiu M H. Hypophosphatemia after major hepatic resection.  Surgery . 1992;  111 281-286
• 136 Schmidt L E, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity.  Hepatology . 2002;  36 659-665
• 137 O'Grady J G, Alexander G JM, Hayllar K M. et al . Early indicators of prognosis in fulminant hepatic failure.  Gastroenterology . 1989;  97 439-445
• 138 Anand A C, Nightingale P, Neuberger J M. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria.  J Hepatol . 1997;  26 62-68
• 139 Shakil A, Kramer D, Mazariegos G, Fung J, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria.  Liver Transplant . 2000;  6 163-169
• 140 Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study.  Lancet . 2002;  359 558-563
• 141 Bernuau J, Samuel D, Durand F. et al . Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: a prospective study.  Hepatology . 1991;  14 49A
• 142 Pauwels A, Mostefa-Kara N, Florent C, Levy V G. Emergency liver transplantation for acute liver failure.  J Hepatol . 1993;  17 124-127
• 143 Izumi S, Langley P G, Wendon J. et al . Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure.  Hepatology . 1996;  23 1507-1511
• 144 Nevens F, Schepens D, Wilmer A. et al . Evaluation of the King's and the Clichy criteria for the selection of OLTX in patients with non-paracetamol induced acute liver failure.  Hepatology . 1998;  28 223A
• 145 Pereira L M B M, Langley P G, Hayllar K M. et al . Coagulation factor V and VII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.  Gut . 1992;  33 98-102
• 146 Harrison P M, O'Grady J G, Keays R T. et al . Serial prothrombin time as prognostic indicator in acetaminophen-induced fulminant hepatic failure.  BMJ . 1990;  301 964-966
• 147 Itai Y, Sekiyama K, Ahmadi T. et al . Fulminant hepatic failure: observation with serial CT.  Radiology . 1997;  202 379-382
• 148 Shakil A O, Jones B C, Lee R G. et al . Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure.  Dig Dis Sci . 2000;  45 334-339
• 149 Mitchell I, Bihari D, Chang R. et al . Earlier identification of patients at risk from acetaminophen-induced acute liver failure.  Crit Care Med . 1998;  26 279-284
• 150 Madl C, Grimm G, Ferenci P. et al . Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure.  Hepatology . 1994;  20 1487-1494
• 151 Lee W M, Galbraith R M, Watt G H. et al . Predicting survival in fulminant hepatic failure using serum Gc protein concentrations.  Hepatology . 1995;  21 101-105
• 152 Acharya S K, Dasarathy S, Kumer T I. et al . Fulminant hepatitis in a tropical population: clinical course, cause and early predictors of outcome.  Hepatology . 1996;  23 1448-1455
• 153 Dhiman R K, Seth A K, Jain S. et al . Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis.  Dig Dis Sci . 1998;  43 1311-1316